论文部分内容阅读
目的:观察分析米索前列醇联合缩宫素对于防治产后出血的临床疗效。方法:抽取在2011年1月至12月间来我院分娩的300例孕妇,随机分成研究组和对照组,研究组使用米索前列醇联合缩宫素治疗产后出血,对照组单纯采用宫缩素治疗,比较两组患者治疗后0.5h、2h、24h后的产后出血量、出血率。结果:研究组中产后出血的有13例,占8.67%,对照组产后出血的有48例,占32%;研究组患者在分娩后0.5h、2h、24h的出血量均少于对照组,差异均具有统计学意义(p<0.05)。结论:采用米索前列醇联合缩宫素防治产后出血能够减少分娩后出血率以及出血的量,值得在临床上推广使用。
Objective: To observe and analyze the clinical efficacy of misoprostol combined with oxytocin in the prevention and treatment of postpartum hemorrhage. Methods: 300 pregnant women who delivered to our hospital from January to December of 2011 were randomly divided into study group and control group. The study group used misoprostol combined with oxytocin to treat postpartum hemorrhage. The control group received only contractions Su-treatment, the two groups of patients after treatment 0.5h, 2h, 24h postpartum hemorrhage, bleeding rate. Results: Postpartum hemorrhage was found in 13 cases (8.67%) in research group and 48 cases (32%) in post-partum control group. The bleeding volume in study group was less than that in control group at 0.5h, 2h and 24h after delivery, The differences were statistically significant (p <0.05). Conclusion: The combination of misoprostol and oxytocin to prevent postpartum hemorrhage can reduce the rate of bleeding after delivery and the amount of bleeding, which is worth popularizing in clinic.